Playlist

Ashgabat to Host Public Legal Consultation Sessions for Citizens

20 May. 07:56

Source

As part of institutional efforts to enhance public access to justice and reinforce civic legal frameworks, a comprehensive public legal counseling session is scheduled to take place in the capital city. The open-door initiative aims to provide residents with direct access to professional legal guidance across multiple branches of domestic statutory and regulatory frameworks.

The centralized advisory service will be administered by an integrated panel of senior experts representing the nation's primary judicial and law enforcement entities. The delegation will include specialists from the Ministry of Justice (Adalat) of Turkmenistan, the General Prosecutor's Office, the Supreme Court, and active practitioners from the Ashgabat City Bar Association, ensuring comprehensive jurisprudential oversight.

The administrative headquarters of the Ministry of Justice of Turkmenistan has been designated as the venue for this multi-agency civic engagement forum. The facility, situated at 150 Archabil Highway in Ashgabat, possesses the necessary logistical infrastructure to accommodate visitors and facilitate structured legal assessments.

The scheduled legal services will be accessible during the morning hours, specifically from 9:00 AM to 12:00 PM on Saturday, May 23. To manage public inquiries, verify documentation requirements, and provide structural details regarding the consultations, the organizing committee has activated the following dedicated hotlines: 39-19-20 and 39-19-21.

















US Scientists Develop Drug That Mimics Exercise Effects

Today in 10:05

Source

American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.

Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.

Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.

Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.